GlassScriptPhysician profile
Joyce A Zeno
NPI 1942278205
$17,226.43
in general payments reported to CMS, 2019-2025
42 companies · $3,233 in 2025
The $3,233 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,058 · 2020: $990 · 2021: $488 · 2022: $1,020 · 2023: $5,257 · 2024: $2,181 · 2025: $3,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,090 · Travel and Lodging: $1,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,089.97 |
| Travel and Lodging | $1,580.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,916.48 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Amplia Mri Quad Crt-D Surescan, Micra |
| Medtronic Vascular, INC. | $2,167.28 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $1,668.79 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $1,404.05 | 2019-2025 | Watchman Access System, Watchman, Watchman Flx |
| Aop Health US, LLC | $1,234.50 | 2025 | Rapiblyk |
| Abbott Laboratories | $819.83 | 2019-2024 | Aveir, Assurity, Amplatzer Amulet |
| Amgen INC. | $738.85 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $720.57 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $714.58 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $650.68 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $536.64 | 2019-2025 | Farxiga, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $534.70 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $482.56 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $474.26 | 2024-2025 | Assure Wcd |
| Scpharmaceuticals INC. | $407.54 | 2023-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $188.74 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amarin Pharma, INC. | $154.21 | 2019-2022 | |
| Esperion Therapeutics, INC. | $139.74 | 2023-2025 | Nexletol |
| Novo Nordisk INC | $139.72 | 2024-2025 | Wegovy, Ozempic |
| Regeneron Healthcare Solutions, INC. | $133.17 | 2019-2025 | Evkeeza |
| Sanofi-Aventis U.S. LLC | $129.10 | 2019-2024 | |
| Alnylam Pharmaceuticals INC. | $117.04 | 2025 | |
| Preventice Services, LLC | $98.75 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $82.15 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $77.65 | 2022-2023 | Verquvo |
| Gilead Sciences, INC. | $55.61 | 2019 | |
| Atricure, INC. | $44.59 | 2019-2021 | |
| Z-Medica, LLC | $41.28 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $38.48 | 2023 | Arcalyst |
| Irhythm Technologies, INC. | $36.62 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Lundbeck LLC | $33.65 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $29.10 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.65 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $25.82 | 2025 | Opsynvi |
| Cvrx, INC. | $24.56 | 2024 | Barostim Neo System |
| Lantheus Medical Imaging, INC. | $24.32 | 2023 | Definity |
| Cardiva Medical, INC. | $23.68 | 2024 | Optowire |
| Chiesi USA, INC. | $23.58 | 2022 | |
| Bridgebio Pharma, INC. | $20.26 | 2025 | Attruby |
| Heartflow, INC. | $18.30 | 2025 | |
| Lilly USA, LLC | $14.28 | 2025 | Zepbound |
| Biotronik INC. | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Zeno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.